Having trouble accessing articles? Reset your cache.

CERE-110: Completed Phase II enrollment

Ceregene said researchers completed enrollment of 49 patients in a double-blind,

Read the full 112 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE